RT Journal Article
SR Electronic
T1 460 Efficacy of adding anti-PD1 immunotherapy to dabrafenib + trametinib (DT) at progression in BRAFv600e mutated anaplastic thyroid carcinoma (BRAFm-ATC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A514
OP A514
DO 10.1136/jitc-2023-SITC2023.0460
VO 11
IS Suppl 1
A1 Hamidi, Sarah
A1 Iyer, Priyanka C
A1 Gule-Monroe, Maria K
A1 Maniakas, Anastasios
A1 Dadu, Ramona
A1 Zafereo, Mark E
A1 Wang, Jennifer
A1 Busaidy, Naifa L
A1 Cabanillas, Maria E
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A514.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.